You have no items in your shopping cart.
Anti-FOLR1 [Farletuzumab (MORAb-003; M3)]
Description
Research Area
Images & Validation
−| Tested Applications | ELISA, FA, Functional Studies, IHC, In vivo, NeA |
|---|---|
| Reactivity | Human, Primate |
Key Properties
−| Host | Human |
|---|---|
| Clonality | Monoclonal |
| Isotype | IgG |
| Clone No. | Farletuzumab (MORAb-003; M3) |
| Immunogen | The original parental mouse antibody was generated by immunizing (BALB/c X C57BL/6) F1 mice by intraperitoneal injection containing cultured LU-75(c) choriocarcinoma cells to produce hybridomas that generated the antibody LK26. Later on the Farletuzumab was generated by CDR grafting technique by taking CDRs of mouse parental clone LK26 and grafting them on human framework regions. |
| Target | FOLR1 |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | PBS with 0.02% Proclin 300. |
| Concentration | 1 mg/ml |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Anti-FOLR1 [Farletuzumab (MORAb-003; M3)] [orb1906393]
ELISA, FA, Functional Studies, IHC, In vivo, NeA
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
![Anti-FOLR1 [Farletuzumab (MORAb-003; M3)]](/images/pub/media/catalog/product/NewWebsite/35/orb1906392_1.png)
Immunofluorescence staining of HeLa cells with anti-FOLR1 antibody Farletuzumab (MORAb-003; M3). Immunofluorescence analysis of paraformaldehyde fixed HeLa cells on Shi-fix™ coverslips stained with Farletuzumab (MORAb-003; M3) (orb1906392) (1:100 dilution) for 1h followed by Alexa Fluor® 488 secondary antibody (1:1000 dilution), showing membrane staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, orb1906392, DAPI, merged channels, and an isotype control. The isotype control was an unknown specificity antibody (orb256458) followed by staining with Alexa Fluor® 488 secondary antibody.
![Anti-FOLR1 [Farletuzumab (MORAb-003; M3)]](/images/pub/media/catalog/product/NewWebsite/35/orb1906392_2.png)
Western blot using anti-FOLR1 antibody Farletuzumab (MORAb-003; M3). HeLa cells lysate (35 µg protein in RIPA buffer) was resolved via SDS-PAGE, and the subsequent blot was probed with Farletuzumab (MORAb-003; M3) (orb1906392) at a concentration of 2 µg/ml before detection using an appropriate secondary antibody. A primary incubation of 1 hour was used, and proteins were detected by chemiluminescence.
Quick Database Links
UniProt Details
−Documents Download
Request a Document
Protocol Information
Anti-FOLR1 [Farletuzumab (MORAb-003; M3)] (orb1906392)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review![Anti-FOLR1 [Farletuzumab (MORAb-003; M3)]](/images/pub/media/catalog/product/NewWebsite/35/orb1906393_1.png)
![Anti-FOLR1 [Farletuzumab (MORAb-003; M3)]](/images/pub/media/catalog/product/NewWebsite/35/orb1906393_2.png)